Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruihao Zhou

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 4, 2019
Mesenchymal stem cell-associated lncRNA in osteogenic differentiationCheng Ju, Renfeng Liu, Yuan-Wei Zhang, et al.
Chinese Medical Journal|November 24, 2025
Comparing the safety and efficacy of propofol, ciprofol, and remimazolam in general anesthesiaZiyue Luo, Ruihao Zhou, Xiran Peng, et al.
BMJ Open|May 16, 2023
Development and evaluation of a data-driven integrated management app for perioperative adverse events: protocol for a mixed-design studyPeiyi Li, Ce Wang, Ruihao Zhou, et al.
Nature Communications|April 23, 2026
Recyclable thermoplastic silicone elastomers from non-carbon heteroatomic polymer backbonesYuanbo Zhang, Feiyang Li, Jia Tian, et al.
Journal of Cellular Physiology|May 19, 2019
Histone deacetylase inhibitor, AR-42, exerts antitumor effects by inducing apoptosis and cell cycle arrest in Y79 cellsSujuan Duan, Xiaona Gong, Xing Liu, et al.
Molecular Cancer|March 22, 2018
The decade of exosomal long RNA species: an emerging cancer antagonistRuihao Zhou, Kaddie Kwok Chen, Jingtao Zhang, et al.
Oncology Letters|July 17, 2018
Histone deacetylase inhibitor AR-42 inhibits breast cancer cell growth and demonstrates a synergistic effect in combination with 5-FURuihao Zhou, Juan Wu, Xiaofeng Tang, et al.
Translational Cancer Research|February 4, 2022
HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatinJun Sun, Xia Qian, Feifei Zhang, et al.
Cancer Cell International|September 26, 2018
LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axisCheng Ju, Ruihao Zhou, Jun Sun, et al.
BMC Geriatrics|May 19, 2026
Cohort profile: PeRiOperative sTress risk assEssment and Clinical decision cohorT (PROTECT), a multi-center observational study based on real-world dataXudong Chen, Ruihao Zhou, Xiran Peng, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 4, 2019
Mesenchymal stem cell-associated lncRNA in osteogenic differentiationCheng Ju, Renfeng Liu, Yuan-Wei Zhang, et al.
Chinese Medical Journal|November 24, 2025
Comparing the safety and efficacy of propofol, ciprofol, and remimazolam in general anesthesiaZiyue Luo, Ruihao Zhou, Xiran Peng, et al.
BMJ Open|May 16, 2023
Development and evaluation of a data-driven integrated management app for perioperative adverse events: protocol for a mixed-design studyPeiyi Li, Ce Wang, Ruihao Zhou, et al.
Nature Communications|April 23, 2026
Recyclable thermoplastic silicone elastomers from non-carbon heteroatomic polymer backbonesYuanbo Zhang, Feiyang Li, Jia Tian, et al.
Journal of Cellular Physiology|May 19, 2019
Histone deacetylase inhibitor, AR-42, exerts antitumor effects by inducing apoptosis and cell cycle arrest in Y79 cellsSujuan Duan, Xiaona Gong, Xing Liu, et al.
Molecular Cancer|March 22, 2018
The decade of exosomal long RNA species: an emerging cancer antagonistRuihao Zhou, Kaddie Kwok Chen, Jingtao Zhang, et al.
Oncology Letters|July 17, 2018
Histone deacetylase inhibitor AR-42 inhibits breast cancer cell growth and demonstrates a synergistic effect in combination with 5-FURuihao Zhou, Juan Wu, Xiaofeng Tang, et al.
Translational Cancer Research|February 4, 2022
HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatinJun Sun, Xia Qian, Feifei Zhang, et al.
Cancer Cell International|September 26, 2018
LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axisCheng Ju, Ruihao Zhou, Jun Sun, et al.
BMC Geriatrics|May 19, 2026
Cohort profile: PeRiOperative sTress risk assEssment and Clinical decision cohorT (PROTECT), a multi-center observational study based on real-world dataXudong Chen, Ruihao Zhou, Xiran Peng, et al.
Pageof 6